Condition
Autologous Haemopoietic Stem Cell Transplant
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 2 (1)
Trial Status
Recruiting1
Terminated1
Enrolling By Invitation1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06802406Not ApplicableRecruiting
Nutrition OUtReach In Systems of Healthcare
NCT06931613Phase 2Enrolling By Invitation
Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment
NCT05524688Phase 1TerminatedPrimary
Beta-glucan and Fatigue in HSCT Survivors
Showing all 3 trials